Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 11, No 2 (2019) Pathogenesis, clinical features, and treatments of depression in Parkinson's disease Abstract  similar documents
I. V. Milyukhina
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..."
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
M. R. Nodel
"... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..."
 
Vol 3, No 1 (2011) Sleep disorders in Parkinson's disease Abstract  similar documents
M. R. Nodel
"... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..."
 
Vol 5, No 2 (2013) Current possibilities of therapy for sleep disorders in Parkinson’s disease Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..."
 
Vol 6, No 4 (2014) The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) Abstract  similar documents
M. R. Sapronova, N. A. Shnaider
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..."
 
Vol 8, No 4 (2016) HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE Abstract  similar documents
M. R. Nodel
"... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..."
 
Online-first Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..."
 
Vol 9, No 1 (2017) The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Abstract  similar documents
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..."
 
Vol 5, No 2 (2013) The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms Abstract  similar documents
E N Gubanova, Natalia Vladimirovna Fedorova
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... Dopamine dysregulation syndrome (DDS) is an iatrogenic disease developing during dopaminergic ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
 
Vol 5, No 2 (2013) Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures Abstract  similar documents
Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov
"... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..."
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 9, No 4 (2017) Sleep disorders in Parkinson’s disease: approaches to treatment and prevention Abstract  similar documents
M. R. Nodel, G. V. Kovrov
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..."
 
Vol 6, No 1 (2014) Apathy in Parkinson's disease patients Abstract  similar documents
M. R. Nodel
"... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..."
 
Vol 2, No 4 (2010) Depression in Parkinson's disease Abstract  similar documents
M. R. Nodel'
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..."
 
Vol 9, No 1 (2017) The genetic basis of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..."
 
Vol 7, No 3 (2015) Experience in using levodopa-benserazide Abstract  similar documents
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..."
 
Vol 9, No 3 (2017) Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..."
 
Vol 1, No 2 (2009) NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE Abstract  similar documents
M. R. Nodel', N. N. Yakhno
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..."
 
Vol 11, No 3 (2019) The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In the past decades, there has been evidence on the relationship between Parkinson's disease (PD ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
"... a positive effect on cognitive functions in patients with Alzheimer’s disease if it is used as an additional ..."
 
Vol 6, No 4 (2014) Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease Abstract  similar documents
V. L. Golubev, A. B. Kamakinova
"... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..."
 
Vol 11, No 3 (2019) The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases Abstract  similar documents
I. V. Miliukhina
"... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease at a young age Abstract  similar documents
D. V. Artemyev
"... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..."
 
Vol 9, No 4 (2017) Neuropsychological pattern of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..."
 
Vol 10, No 4 (2018) Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease Abstract  similar documents
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease Abstract  similar documents
I. G. Tishkova, I. S. Preobrazhenskaya
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..."
 
Vol 3, No 3 (2011) Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) Abstract  similar documents
M. R. Nodel
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..."
 
Vol 10, No 3 (2018) Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis Abstract  PDF (Eng)  similar documents
T. K. Davydova, A. A. Tappakhov, T. E. Popova, E. E. Konnikova, A. D. Alekseeva, D. A. Popov
"... disturbances, and pyramidal syndrome, is characteristic of some neurodegenerative diseases, for example ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..."
 
Vol 11, No 2 (2019) Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease Abstract  similar documents
A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko
"... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..."
 
Vol 3, No 4 (2011) Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease Abstract  similar documents
M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev
"... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using the examination protocol ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..."
 
Vol 10, No 4 (2018) Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease Abstract  similar documents
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..."
 
Vol 1, No 1 (2009) VESTIBULAR VERTIGO Abstract  similar documents
M. V. Zamergrad
"... vertigo, Meniere's disease, vestibular neuroni-tis, vestibular migraine, cerebrovascular diseases ..."
 
Vol 5, No 3 (2013) Role of anxiety and depressive disorders in the genesis of psychosomatic disorders Abstract  similar documents
Aleksandr Anatolyevich Shatenshtein
"... of psychosomatic diseases (coronary heart disease, hypertensive disease, duodenal ulcer disease, asthma ..."
 
Vol 4, No 2 (2012) Strokes in mitochondrial diseases Abstract  similar documents
N V Pizova
"... It is suggested that mitochondrial diseases might be identified in 22—33% of cryptogenic stroke ..."
 
Vol 7, No 3 (2015) Some clinical and diagnostic features of patients with new-onset epilepsy in the presence of chronic cerebrovascular disease Abstract  similar documents
D. R. Khasanova, T. V. Danilova, Z. K. Latypova
"... of chronic cerebrovascular disease. Patients and methods. A total of 304 patients (a study group of 174 ..."
 
Vol 10, No 1 (2018) Chronic cerebrovascular diseases: pathogenetic mechanisms, clinical manifestations, and approaches to therapy Abstract  similar documents
N. V. Pizova
"... The paper gives data on the incidence of cerebrovascular diseases (CVD) and the pathogenetic ..."
 
Vol 1, No 3-4 (2009) DEPRESSION AND CARDIOVASCULAR DISEASES Abstract  similar documents
L. V. Romasenko
"... of a somatic disease in the genesis of developing symptomatic somatogenic and psychogenic mental disorders ..."
 
Vol 4, No 3 (2012) Current drug treatments for vestibular disorders Abstract  similar documents
Maksim Valeryevich Zamergrad
"... There has recently been significant progress in the treatment of different diseases accompanied ..."
 
Vol 11, No 3 (2019) Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? Abstract  similar documents
G. R. Tabeeva, E. A. Kirjanova
"... on the clinical manifestation, severity, and rate of progression of CI. Alzheimer's disease (AD) and vascular CI ..."
 
Vol 4, No 4 (2012) Use of vitamin B 1 preparations with different solubility in fats/oils and aqueous media: Clinical and pharmacological aspects Abstract  similar documents
Galina Vladislavovna Ramenskaya, O A Petukhova, V V Smirnov
"... neurological diseases has been today registered on the Russian pharmaceutical market. The most used agents ..."
 
Vol 4, No 2 (2012) Clinical characteristics of multiple sclerosis in the Tomsk region Abstract  similar documents
V M Alifirova, M A Titova
"... moderate neurologic deficit and moderate disease progression. The women were observed to exhibit a more ..."
 
Vol 6, No 4 (2014) The development and treatment of Alzheimer’s disease: Some genetic aspects Abstract  similar documents
I. S. Preobrazhenskaya, N. S. Snitskaya
"... The paper gives an update on the occurrence and development of Alzheimer’s disease (AD ..."
 
Vol 7, No 3 (2015) Hereditary cerebellar ataxias with polyneuropathy Abstract  similar documents
Svetlana Vasilyevna Kopishinskaya
"... ataxias should be started by ruling out the hereditary nature of the disease, which is verified ..."
 
Vol 7, No 4 (2015) Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations Abstract  similar documents
A. N. Belova, D. N. Shakurova, E. V. Gayazova
"... The efficacy of naftidrofuryl in treating cerebrovascular diseases is analyzed on the basis ..."
 
Vol 11, No 1 (2019) Antidepressant therapy in patients with cardiovascular diseases Abstract  similar documents
V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya
"... Depression is the most common form of mental illness in patients with cardiovascular diseases (CVD ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive and neuropsychiatric disorders in extrapyramidal diseases Abstract  similar documents
O. S. Levin, M. A. Anikin, E. E. Vasenina
"... of Parkinson’s disease or Huntington’s disease in persons who are predisposed to these diseases. Moreover ..."
 
Vol 5, No 3 (2013) Comorbidity of chronic pain and depression in neurological patients Abstract  similar documents
Gyuzel Rafkatovna Tabeeva
"... , the development of therapeutic resistance, and the risk of disease recurrence. The epidemiology and clinical ..."
 
Vol 4, No 1 (2012) Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..."
 
Vol 4, No 3 (2012) Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases Abstract  similar documents
Vladimir Ernstovich Medvedev
"... Psychopathological disorders in patients with cardiovascular diseases (CVD) are treated ..."
 
Vol 5, No 2 (2013) Locomotor therapy with extended-release crystalline glucocorticoids Abstract  similar documents
Vladimir Vasilyevich Badokin
"... Topical glucocorticoid (GC) therapy for locomotor diseases is an extremely important component ..."
 
Vol 11, No 4 (2019) Hippocampal magnetic resonance imaging morphometry and neuropsychological parameters in patients with Alzheimer's disease Abstract  similar documents
N. N. Yakhno, N. N. Koberskaya, V. A. Perepelov, D. S. Smirnov, V. I. Solodovnikov, M. I. Trufanov, V. N. Gridin
"... Alzheimer's disease (AD) is the leading cause of dementia in the population. Difficulties ..."
 
Vol 6, No 2 (2014) Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization Abstract  similar documents
D.S. Danilov
"... diseases is discussed. Recommendations are given to improve its quality in cardiovascular, chronic ..."
 
Vol 7, No 1 (2015) Vascular cognitive impairments in chronic kidney disease Abstract  similar documents
I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva
"... kidney disease (CKD) and to assess an association of CIs with the signs of vascular wall remodeling ..."
 
Vol 9, No 4 (2017) Neurological complications of alcoholism Abstract  similar documents
I. I. Nikiforov, M. M. Rakitin, A. G. Merkin, P. V. Aronov, G. P. Kostyuk, D. V. Savelyev, R. N. Isaev, A. V. Kazantsev, V. A. Priyatel, I. A. Nikiforov
"... practice. They lead to aggravated alcoholic disease, its more frequent recurrences, and intensified ..."
 
Vol 9, No 4 (2017) Current approaches to diagnosing and treating major neurocognitive disorder Abstract  similar documents
A. A. Kulesh, V. V. Shestakov
"... . It  characterizes in detail Alzheimer's disease (AD) that is a cause of  MNCD in 50–70% of cases. The current ..."
 
Vol 8, No 1 (2016) Role of lipoprotein (a) in the development of ischemic stroke and other cardiovascular diseases Abstract  similar documents
N. A. Pizov, N. V. Pizova
"... lipoprotein (a) (Lp (a)) in the development of ischemic stroke and other cardiovascular diseases. It shows ..."
 
Vol 7, No 2 (2015) Cognitive impairments in some cardiovascular and somatic diseases Abstract  similar documents
N. V. Pizova
"... of cognitive impairments (CIs) in different autoimmune, endocrine, and infectious diseases: systemic lupus ..."
 
Vol 7, No 3 (2015) Cognitive impairments in common and rare somatic diseases Abstract  similar documents
Natalia Vyacheslavovna Pizova
"... of cognitive impairments (CIs) in different autoimmune, endocrine, and infectious diseases, such as systemic ..."
 
Vol 8, No 2 (2016) Vascular and neurodegenerative cognitive impairments: a clinical case report Abstract  similar documents
V. V. Zakharov, N. V. Vakhnina
"... patient management and disease prognosis. The paper describes a patient with moderate CI, with respect ..."
 
Vol 9, No 2 (2017) Cognitive and non-cognitive neuropsychiatric disorders in dementia and methods of their correction Abstract  similar documents
E. G. Mendelevich
 
Vol 9, No 3 (2017) Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program Abstract  similar documents
G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva
"... with initial manifestations of chronic cerebrovascular disease (CVD) in outpatient neurological and therapeutic ..."
 
Vol 1, No 2 (2009) DEPRESSION IN CEREBROVASCULAR DISEASES Abstract  similar documents
T. G. Voznesenskaya
"... The paper discusses the topical problem of depression in cerebrovascular diseases. It shows its ..."
 
Vol 11, No 1 (2019) The modern concept of cognitive reserve Abstract  similar documents
N. N. Koberskaya, G. R. Tabeeva
"... reserve function in the health and disease of the brain are to activate its neuronal connections ..."
 
1 - 70 of 154 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)